Spine Top Stories Curiteva Surpasses 2,000 Procedures with Inspire®C Cervical Trabecular PEEK™ with HAFUSE® Technology byJosh SandbergDecember 4, 2024
Spine InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury byJosh SandbergMarch 9, 2023
Spine Top Stories Curiteva Inc. Announces FDA 510(k) Clearance for Inspire 3D Porous PEEK HAFUSE Cervical Interbody System byJosh SandbergFebruary 14, 2023
Neuro Spine InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery byChris StewartJune 8, 2022
Neuro Spine InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study byChris StewartJune 2, 2022
Biologics Neuro InVivo Therapeutics Announces Sixth Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold™ byJosh SandbergJanuary 25, 2017
Biologics InVivo Therapeutics Announces INSPIRE’S 29th Clinical Site: Rhode Island Hospital byJosh SandbergJanuary 11, 2017
Neuro InVivo Therapeutics Announces Fifth Patient Conversion in INSPIRE Study of the Neuro-Spinal Scaffold™ byJosh SandbergAugust 17, 2016
Biologics InVivo Therapeutics Announces Ben Taub Hospital/Baylor College of Medicine as New Site for INSPIRE Study byJosh SandbergJuly 18, 2016
Hospitals InVivo Therapeutics Announces Approval for INSPIRE Pivotal Probable Benefit Clinical Study of the Neuro-Spinal Scaffold™ byJosh SandbergJanuary 5, 2016
